Design, Development and Evaluation of Gliclazide Tablets for Non-Insulin Dependent Diabetes Mellitus
نویسندگان
چکیده
منابع مشابه
Non-insulin-dependent diabetes mellitus.
Non-insulin-dependent diabetes mellitus (NIDDM) occurs predominantly after the age of 50 years but is not easy to distinguish from late onset insulin-dependent diabetes. It is likely that misclassification is rare in a Caucasian population. Whilst NIDDM is widely believed to be genetically determined, recent epidemiological observations have consistently revealed statistical associations betwee...
متن کاملInsulin-Dependent Diabetes Mellitus
From the School of Nursing (Drs Boehm, Schlenk, and Ronis and Ms Powers) and the Michigan Diabetes Research and Training Center, School of Medicine (Ms Funnell), University of Michigan, and the Department of Veteran’s Affairs (Dr Ronis), Ann Arbor, Michigan. Correspondence to Susan Boehm, PhD, Associate Professor and Dean, Student Affairs, The University of Michigan, School of Nursing, 400 Nort...
متن کاملOptimum Insulin Therapy in Non-insulin-dependent Diabetes Mellitus *
However, it has also been recognized that the treatment of NIDDM patients frequently is inadequate even in those patients who should achieve the target range. In a recent population based cohort the median of glycosylated haemoglobin was 10.2% in NIDDM patients treated with diet or oral hypoglycemic agents (OHA) and 11.8% in NIDDM patients who used insulin. In a 5 year follow-up study of NIDDM ...
متن کاملA variant insulin promoter in non-insulin-dependent diabetes mellitus.
To test the hypothesis that alterations in regulatory regions of the insulin gene occur in a subset of patients with non-insulin-dependent diabetes mellitus (NIDDM), the promoter region was studied by polymerase chain reaction (PCR) amplification directly from genomic DNA, followed by high-resolution polyacrylamide gel electrophoresis under nondenaturing conditions. By using this method a previ...
متن کاملComparison of gliclazide and glibenclamide treatment in non-insulin-dependent diabetes.
Gliclazide has been reported to decrease platelet function and to inhibit the progression of diabetic retinopathy in addition to having a hypoglycemic effect. To confirm these effects we performed a double-blind randomized study using glibenclamide as a reference drug. Thirty-eight hospitals from eight university groups in Japan performed the study on type II diabetic subjects. Evaluation of bl...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Asian Journal of Pharmaceutical Research and Development
سال: 2020
ISSN: 2320-4850
DOI: 10.22270/ajprd.v8i3.736